ANUHPHR

Anuh Pharma Limited

Anuh Pharma Limited has informed the Exchange regarding a proposal to invest in manufacturing assets for expansion of production capacity and to avail a loan of up to ₹ 75 crs for the purchase of manufacturing assets.

Anuh Pharma Limited

Anuh Pharma Limited has informed the Exchange regarding Outcome of Board Meeting held on October 13, 2026 for Investment and availing of Loan. The Board of Directors approved the investment in manufacturing assets for expansion of the Company’s production capacity and the proposal to avail a loan of up to ₹ 75 crs for the purchase of manufacturing assets.

Anuh Pharma Limited

Anuh Pharma Limited has informed the Exchange about Certificate under SEBI (Depositories and Participants) Regulations, 2018, confirming dematerialization of securities up to 30th September 2026.

Anuh Pharma Limited

Anuh Pharma Limited has informed the Exchange regarding the Trading Window closure pursuant to SEBI (Prohibition of Insider Trading) Regulations, 2015.

Anuh Pharma Limited

Anuh Pharma Limited has informed the Exchange about orders passed regarding receipt of Demand Order under Section 156 of the Income Tax Act, 1961. The company has received a Notice of Demand Order for an amount of Rs. 9,93,206/- on account of disallowances and deductions claimed. The company is in process of filing an appeal before the CIT against the said order.

Anuh Pharma Limited

Anuh Pharma Limited has released its Q1 FY 2027 investor presentation, showcasing a confident start to the year with profit growth outpacing revenue, driven by a richer product mix, disciplined cost control, and better throughput from existing assets. The company has secured USFDA and EU GMP clearances, positioning it for growth in regulated markets.

Anuh Pharma Limited

Anuh Pharma Limited has informed the Exchange about change in Management. The Company has reappointed Mr. Bipin Nemchand Shah and Mr. Arun Lalchand Todarwal as Non-Executive Non-Independent Directors, and Mr. Ankit Kishor Chande as a Cost Auditor for the financial year ending March, 2027. The Company has also revised the remuneration payable to Mr. Ritesh B. Shah and Mr. Vivek Shah, and approved the adoption of new Memorandum of Association and Articles of Association.

Anuh Pharma Limited

Anuh Pharma Limited has informed the Exchange regarding the appointment of Mr. Bipin N. Shah, Mr. Arun L. Todarwal, and Mr. Ankit Chande as Directors of the company.

Anuh Pharma Limited

Anuh Pharma Limited has informed the Exchange about General Updates under Regulation 30, including the reappointment of two Non-Executive Directors, revision in remuneration of Joint Managing Directors, and adoption of new Memorandum of Association and Articles of Association.

Anuh Pharma Limited

Anuh Pharma Limited has submitted the Voting Results and Scrutinizers report of its 66th Annual General Meeting held on August 12, 2026. The meeting was conducted through Video Conferencing and had a total of 45 shareholders present, with 17 promoters and 28 public shareholders. The resolutions passed included the adoption of audited financial statements, declaration of a dividend of Rs. 1.50 per equity share, and the appointment of directors.

Anuh Pharma Limited

Anuh Pharma Limited has informed the Exchange regarding Proceedings of 66th Annual General Meeting held on August 12, 2026, where resolutions related to audited financial statements, dividend declaration, director appointments, and remuneration revisions were passed.

Anuh Pharma Limited

Anuh Pharma Limited has published unaudited financial results for the quarter ended June 30, 2026, in newspapers and on its website.

Anuh Pharma Limited

Anuh Pharma Limited has informed the Exchange regarding 'Adoption of Revised Policy of Related Party Transactions.' The company has also announced its unaudited financial results for the quarter ended 30th June, 2026, which show a profit of Rs. 1,142.49 lakhs.

Anuh Pharma Limited

Anuh Pharma Limited has received a request for withdrawal of an application for reclassification of shareholding from Promoter & Promoter Group to Public Category.

Anuh Pharma Limited

Anuh Pharma Limited has announced its unaudited financial results for the quarter ended 30th June, 2026, showing revenue from operations of Rs. 19,381.04 lakhs, a 9.22% increase from the previous quarter, and a net profit of Rs. 1,142.49 lakhs.

Anuh Pharma Limited

Anuh Pharma Limited has submitted its unaudited financial results for the quarter ended June 30, 2026, which were reviewed by the Audit Committee and approved by the Board of Directors. The results show a profit before tax of Rs. 1,692.81 lakhs, a 10.4% increase from the same quarter last year. The company's earnings per equity share for the quarter is Rs. 1.14.

Anuh Pharma Limited

Anuh Pharma Limited has dispatched physical communications to shareholders who have not registered their email addresses and informed about the 66th Annual General Meeting and availability of the Annual Report for the financial year 2025-26.

Anuh Pharma Limited

Anuh Pharma Limited has informed the Exchange about the publication of a newspaper advertisement regarding the Notice of the 66th Annual General Meeting, Book Closure, and e-voting information.

Anuh Pharma Limited

Anuh Pharma Limited has informed the Exchange regarding Notice of Annual General Meeting to be held on August 12, 2026, to consider various resolutions including adoption of audited financial statements, declaration of dividend, re-appointment of directors, and revision in remuneration of a joint managing director.

Anuh Pharma Limited

Anuh Pharma Limited has informed the Exchange about Certificate under SEBI (Depositories and Participants) Regulations, 2018, confirming no dematerialization of equity shares during the quarter ended 30th June 2026.